Patents by Inventor Roland Blantz

Roland Blantz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of improved diuresis in individuals with impaired renal function
    Patent number: 7579331
    Abstract: Disclosed is a pharmaceutical composition comprising a therapeutically effective amount of KW-3902, or a salt, ester, amide, metabolite, or prodrug thereof, and a non-adenosine modifying diuretic. Also disclosed are methods of inducing a diuretic effect in an animal comprising the step of administering a therapeutically effective amount of KW-3902, or a salt, ester, amide, metabolite, or prodrug thereof, in combination with second pharmaceutical composition capable of inducing a diuretic effect.
    Type: Grant
    Filed: April 23, 2004
    Date of Patent: August 25, 2009
    Assignee: Novacardia, Inc.
    Inventors: Kenneth J. Widder, Lauren Otsuki, Howard C. Dittrich, Scott Thomson, Roland Blantz
  • Method of improved diuresis in individuals with impaired renal function
    Publication number: 20060035911
    Abstract: Disclosed is a pharmaceutical composition comprising a therapeutically effective amount of KW-3902, or a salt, ester, amide, metabolite, or prodrug thereof, and a non-adenosine modifying diuretic. Also disclosed are methods of inducing a diuretic effect in an animal comprising the step of administering a therapeutically effective amount of KW-3902, or a salt, ester, amide, metabolite, or prodrug thereof, in combination with second pharmaceutical composition capable of inducing a diuretic effect.
    Type: Application
    Filed: October 11, 2005
    Publication date: February 16, 2006
    Inventors: Kenneth Widder, Lauren Otsuki, Howard Dittrich, Scott Thomson, Roland Blantz
  • Method of improved diuresis in individuals with impaired renal function
    Publication number: 20060030572
    Abstract: Disclosed is a pharmaceutical composition comprising a therapeutically effective amount of KW-3902, or a salt, ester, amide, metabolite, or prodrug thereof, and a non-adenosine modifying diuretic. Also disclosed are methods of inducing a diuretic effect in an animal comprising the step of administering a therapeutically effective amount of KW-3902, or a salt, ester, amide, metabolite, or prodrug thereof, in combination with second pharmaceutical composition capable of inducing a diuretic effect.
    Type: Application
    Filed: October 11, 2005
    Publication date: February 9, 2006
    Inventors: Kenneth Widder, Lauren Otsuki, Howard Dittrich, Scott Thomson, Roland Blantz
  • Method of improved diuresis in individuals with impaired renal function
    Publication number: 20050004145
    Abstract: Disclosed is a pharmaceutical composition comprising a therapeutically effective amount of KW-3902, or a salt, ester, amide, metabolite, or prodrug thereof, and a non-adenosine modifying diuretic. Also disclosed are methods of inducing a diuretic effect in an animal comprising the step of administering a therapeutically effective amount of KW-3902, or a salt, ester, amide, metabolite, or prodrug thereof, in combination with second pharmaceutical composition capable of inducing a diuretic effect.
    Type: Application
    Filed: April 23, 2004
    Publication date: January 6, 2005
    Inventors: Kenneth Widder, Lauren Otsuki, Howard Dittrich, Scott Thomson, Roland Blantz
  • Method of treatment of disease using an adenosine A1 receptor antagonist
    Publication number: 20040229901
    Abstract: Disclosed are pharmaceutical composition comprising a beta-blocker and an adenosine A1 receptor antagonist (AA1RA), an angiotensin converting enzyme (ACE) inhibitor and an adenosine A1 receptor antagonist (AA1RA), and an angiotensin II receptor blocker (ARB) and an adenosine A1 receptor antagonist (AA1RA). Also disclosed are methods of treating cardiovascular disease, renal disease, alkalosis, or diabetic nephropathy comprising identifying a patient in need of such treatment, and administering a pharmaceutical composition disclosed herein to said patient.
    Type: Application
    Filed: February 23, 2004
    Publication date: November 18, 2004
    Inventors: Lauren Otsuki, Howard C. Dittrich, Kenneth J. Widder, Roland Blantz, Scott Thomson